CV Sciences, Inc. (CVSI) financial statements (2022 and earlier)

Company profile

Business Address 10070 BARNES CANYON ROAD
SAN DIEGO, CA 92121
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

9/30/2021
TTM
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments 4,0249,10712,6842,013782518
Cash and cash equivalents 4,0249,10712,6842,013782518
Receivables 1,1262,1773,3401,5083601,488
Inventory, net of allowances, customer advances and progress billings 8,8409,9717,1322,8232,85214,134
Inventory 8,8409,9717,1322,8232,85214,134
Prepaid expense 2,37210,6112,059813551451
Other current assets    400  
Other undisclosed current assets 501501251379276 
Total current assets: 16,86332,36725,4667,9354,82116,592
Noncurrent Assets
Inventory, Noncurrent   1,4185,6676,479 
Operating lease, right-of-use asset 3,0578,709
Property, plant and equipment 2,8773,6152,8442,083243440
Long-term investments and receivables     390 
Accounts and financing receivable, after allowance for credit loss     390 
Intangible assets, net (including goodwill) 6,5186,5546,5896,6256,66010,264
Goodwill 2,7882,7882,7882,7882,7884,644
Intangible assets, net (excluding goodwill) 3,7303,7663,8013,8363,8725,620
Other noncurrent assets 1,3101,442    
Other undisclosed noncurrent assets   585400  
Total noncurrent assets: 13,76220,32011,43614,77513,77110,703
TOTAL ASSETS: 30,62552,68736,90222,71018,59227,295
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities 11,48212,4733,9182,6109021,182
Accounts payable 1,6771,6171,245678524659
Accrued liabilities 9,80510,8562,6731,932378523
Debt 2,1747234747262,0241,021
Derivative instruments and hedges, liabilities     223 
Business combination, contingent consideration, liability      250
Other undisclosed current liabilities 680     
Total current liabilities: 14,33613,1964,3923,3363,1492,453
Noncurrent Liabilities
Long-term debt and lease obligation 3,4679,517 850679 
Long-term debt, excluding current maturities    850679 
Operating lease, liability 3,4679,517
Liabilities, other than long-term debt 1,6108271,3292,1421,5561,556
Deferred revenue and credits1,067  
Deferred revenue 1,453 
Contract with customer, liability1,329
Deferred tax liabilities, net 1,0751,5561,556
Deferred income tax liabilities 157421
Other liabilities  406    
Other undisclosed noncurrent liabilities   1,065   
Total noncurrent liabilities: 5,07710,3442,3942,9922,2351,556
Total liabilities: 19,41323,5406,7866,3295,3844,009
Stockholders' equity
Stockholders' equity attributable to parent 11,21229,14730,11616,38113,20823,286
Common stock 10109965
Additional paid in capital 75,12370,77455,13451,40043,33339,271
Accumulated deficit (63,921)(41,637)(25,027)(35,028)(30,131)(15,989)
Total stockholders' equity: 11,21229,14730,11616,38113,20823,286
TOTAL LIABILITIES AND EQUITY: 30,62552,68736,90222,71018,59227,295

Income statement (P&L) ($ in thousands)

9/30/2021
TTM
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues 24,42953,69648,24420,67911,06111,529
Revenue, net230 5,444
Cost of revenue (13,420)(18,608)(14,366)(6,191)(4,063)(4,421)
Cost of goods and services sold  (248) (854)(4,060)(377)
Gross profit: 11,00935,08833,87814,4896,9987,108
Operating expenses (33,601)(52,328)(23,631)(19,349)(14,289)(19,075)
Other undisclosed operating income (loss)     (5,782)757
Operating income (loss): (22,592)(17,240)10,247(4,860)(13,074)(11,210)
Nonoperating expense
(Other Nonoperating expense)
   (153)(519)(1,068)(1,024)
Interest and debt expense   (153)(189)(1,087)(969)
Income (loss) from continuing operations before equity method investments, income taxes: (22,592)(17,240)9,941(5,567)(15,228)(13,202)
Other undisclosed income (loss) from continuing operations before income taxes (9)151531891,087 
Income (loss) from continuing operations before income taxes: (22,601)(17,225)10,094(5,379)(14,141)(13,202)
Income tax expense (benefit) 317615(93)482  
Income (loss) before gain (loss) on sale of properties: (22,284)(16,610)10,001(4,897)(14,141)(13,202)
Other undisclosed net income      969
Net income (loss) available to common stockholders, diluted: (22,284)(16,610)10,001(4,897)(14,141)(12,233)

Comprehensive Income ($ in thousands)

9/30/2021
TTM
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net income (loss): (22,284)(16,610)10,001(4,897)(14,141)(12,233)
Comprehensive income (loss), net of tax, attributable to parent: (22,284)(16,610)10,001(4,897)(14,141)(12,233)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: